Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic

Figure 4

Persistence on adalimumab treatment (a) all population, (b) non-smokers, smokers/ex-smokers, (c) normal and overweight/obese patients.

(a)

(b)

(c)